Product Information
NAPHCON-A EYE DROPS is a brand product labeled by Alcon Laboratories, Inc., priced at $0.5574 per ML under NDC 00065008515. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 8, 1994.
Strength
.25; 3 mg/mL; mg/mL
Manufacturer
Alcon Laboratories, Inc.NDC
00065008515
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATEApproval Type
New Drug (NDA)
FDA Application
NDA020226FDA Approved
6/8/1994
On Market Since
6/8/1994
Price Statistics
The NADAC for NAPHCON-A EYE DROPS has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 9.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5574 per ML |
|---|---|
| All-time high | $0.5620 (Jul 15, 2026) |
| All-time low | $0.4994 (May 20, 2015) |
| 52-week high | $0.5620 |
| 52-week low | $0.5539 |
| Median price | $0.5149 |
| Average price | $0.5227 |
| Largest weekly change | +6.9% (Jan 18, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the naphazoline hydrochloride and pheniramine maleate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alcon Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
naphazoline hydrochloride and pheniramine maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NAPHCON-A EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for NAPHCON-A EYE DROPS, manufactured by Alcon Laboratories, Inc., is $0.5574 per ML (NDC 00065008515), effective Sep 30, 2026.
How has the price of NAPHCON-A EYE DROPS changed over time?
Over the history we have for it, the NADAC for NAPHCON-A EYE DROPS has risen 9.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NAPHCON-A EYE DROPS?
Since Nov 28, 2013, the NADAC for NAPHCON-A EYE DROPS has ranged from a low of $0.4994 (May 20, 2015) to a high of $0.5620 (Jul 15, 2026), with a median of $0.5149 per ML.
Are there cheaper alternatives to NAPHCON-A EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of NAPHCON-A EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NAPHCON-A EYE DROPS?
NAPHCON-A EYE DROPS (NDC 00065008515) is labeled by Alcon Laboratories, Inc., and CMS classifies it as a brand product.